Table 4.
Feasibility
| Author, year | No. of patients eligible for the study | Included patients (% of eligible) |
No. of patients completed post-test (%) | Statistical power calculation; estimated number of participants (actually included/planned) |
Exercise adherence | Adverse events |
|---|---|---|---|---|---|---|
| Arrieta et al [30], 2019 | 368 | 301 (82%) | 249 (83%) |
Power calculation presented; (301/300) |
Completed phone calls: 81.1% SR performance of PA: 70.1% |
NR |
| Maréchal et al [31], 2019 | (NR/secondary analysis) | 14 (NR/secondary analysis) | 14 (100%/ secondary analysis) | NR | NR | No adverse events |
| Sajid et al [32], 2016 | NR | 19 (NR) | 18 (95%) |
Power calculation presented; (19/18) |
NR | No adverse events |
| Miki et al [33], 2014 | 146 | 78 (53%) | 78 (100%) |
Power calculation presented; (78/62 participants) |
Feedback ergometer sessions: 100% | No adverse events |
Abbreviations: No. Number, NR Not reported, PA Physical activity, SR Self-reported